Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.
The vector of anti-TNFRSF13C chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target Human TNFRSF13C. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-TNFRSF13C antibody linked to CD28 and CD3_ signaling domains. And the vector product was designed for the treatment of Acute myeloid leukemia (AML).
Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.